Home Cart 0 Sign in  
X

[ CAS No. 16732-73-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 16732-73-3
Chemical Structure| 16732-73-3
Chemical Structure| 16732-73-3
Structure of 16732-73-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 16732-73-3 ]

Related Doc. of [ 16732-73-3 ]

Alternatived Products of [ 16732-73-3 ]

Product Details of [ 16732-73-3 ]

CAS No. :16732-73-3 MDL No. :MFCD01548823
Formula : C10H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :XNBGANWAZJWOHS-UHFFFAOYSA-N
M.W : 191.18 Pubchem ID :410327
Synonyms :

Calculated chemistry of [ 16732-73-3 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 51.75
TPSA : 62.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.85 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 2.28
Log Po/w (WLOGP) : 1.87
Log Po/w (MLOGP) : 0.8
Log Po/w (SILICOS-IT) : 1.87
Consensus Log Po/w : 1.64

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.81
Solubility : 0.299 mg/ml ; 0.00157 mol/l
Class : Soluble
Log S (Ali) : -3.23
Solubility : 0.114 mg/ml ; 0.000594 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.79
Solubility : 0.312 mg/ml ; 0.00163 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.46

Safety of [ 16732-73-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 16732-73-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 16732-73-3 ]
  • Downstream synthetic route of [ 16732-73-3 ]

[ 16732-73-3 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 16732-73-3 ]
  • [ 70555-46-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6270 - 6282
[2] Synthetic Communications, 1992, vol. 22, # 14, p. 2077 - 2102
  • 2
  • [ 16732-73-3 ]
  • [ 40047-23-2 ]
Reference: [1] ChemMedChem, 2018, vol. 13, # 23, p. 2522 - 2529
[2] Letters in Organic Chemistry, 2011, vol. 8, # 1, p. 48 - 52
  • 3
  • [ 15050-04-1 ]
  • [ 16732-73-3 ]
YieldReaction ConditionsOperation in experiment
4.6 g With water; lithium hydroxide In tetrahydrofuran at 20℃; for 16 h; 6-Methoxy-1H-indole-2-carboxylic acid ethyl ester (5.0 g) was treated with lithium hydroxide (2.33 g) in THF (90 mL) followed by water (30 mL) and stirred at ambient temperature for 16 h. The solution was acidified with 10percent hydrochloric acid, diluted with water and extracted with ethyl acetate. The organic extracts were washed with brine, dried over sodium sulfate, filtered, and concentrated to afford 6-Methoxy-1H-indole-2-carboxylic acid (4.60 g). This material (4.64 g) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (5.60 g) in dichloromethane (200 mL) were treated with N-methylpiperazine (3.23 mL) and stirred at ambient temperature for 16 h. The reaction mixture was poured into dichloromethane (200 mL), washed with water, saturated sodium hydrogencarbonate solution and then brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified via silica gel chromatography (0-10percent 2M ammonia in methanol/dichloromethane) to give (6-Methoxy-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-methanone (6.60 g). This material (0.16 g) was dissolved in dichloromethane (10 mL). At room temperature, 1 M boron tribromide (1.5 mL) was added dropwise. The reaction mixture was heated to reflux overnight, and then cooled, quenched with saturated sodium hydrogencarbonate solution, and extracted with dichloromethane. The organic extracts were washed with brine, dried over sodium sulfate, filtered, and concentrated. The residue was purified via silica gel chromatography (0-10percent 2M ammonia in methanol/dichloromethane) to give the title compound
1.2 g With sodium hydroxide In ethanol; water at 70℃; for 1 h; A suspension of ethyl 6-methoxy-1H-indole-2-carboxylate (1.5 g6.84 mmol) in ethanol (80 mL) was treated with a 1 mol/L aqueous NaOH solution (14 mL) and heated at 70°C for 1 h. After the reaction, the solvent was evaporated in vacuo and 100 mL water was added. The solution then was washed by CH2Cl2 (100 mL×3) and the water phase was acidified with 2 mol/L HCl and the precipitate formed was isolated by filtration, and washed with water to give 1.2 g white solid. LC-MS: m/z= 189.1 [M-H]-. m.p. 203-205°C.
1.2 g at 70℃; for 1 h; To a 100 mL eggplant flask was added ethyl 6-methoxy-1H-indole-2-carboxylate (1.5 g, 6.84 mmol)1mol / L aqueous sodium hydroxide solution 14mL,70 reflux 1h,Stop the reaction.Methanol was distilled off,Add 100mL water,The aqueous layer was washed with dichloromethane (100 mL × 3)PH adjusted to 2 with 2N hydrochloric acid,Precipitation,Stirring,Suction filtration,Washed,The filter cake was dried to give 6-methoxy-1H-indole-2-carboxylic acid (1.2 g) as a white solid.The product was separated and purified directly to the next reaction.
Reference: [1] Patent: US2003/207893, 2003, A1,
[2] Patent: WO2004/22061, 2004, A1, . Location in patent: Page/Page column 71
[3] Patent: EP1373204, 2016, B1, . Location in patent: Paragraph 0216
[4] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 9, p. 1943 - 1948
[5] Patent: CN106478606, 2017, A, . Location in patent: Paragraph 0122; 0123; 0128; 0129
  • 4
  • [ 98081-83-5 ]
  • [ 16732-73-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6270 - 6282
[2] Synthetic Communications, 1992, vol. 22, # 14, p. 2077 - 2102
[3] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 5, p. 483 - 486
[4] Journal of Medicinal Chemistry, 2008, vol. 51, # 6, p. 1849 - 1860
[5] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 3, p. 950 - 954
  • 5
  • [ 143702-29-8 ]
  • [ 16732-73-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6270 - 6282
[2] Synthetic Communications, 1992, vol. 22, # 14, p. 2077 - 2102
  • 6
  • [ 123-11-5 ]
  • [ 16732-73-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 6, p. 1740 - 1742
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 9, p. 1943 - 1948
[3] Patent: CN106478606, 2017, A,
  • 7
  • [ 3189-13-7 ]
  • [ 124-38-9 ]
  • [ 16732-73-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 13, p. 2003 - 2010
  • 8
  • [ 98081-75-5 ]
  • [ 16732-73-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 6, p. 1740 - 1742
  • 9
  • [ 536-90-3 ]
  • [ 16732-73-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 3, p. 950 - 954
  • 10
  • [ 15384-39-1 ]
  • [ 16732-73-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 3, p. 950 - 954
  • 11
  • [ 24513-03-9 ]
  • [ 16732-73-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 9, p. 1943 - 1948
  • 12
  • [ 16792-46-4 ]
  • [ 16732-73-3 ]
Reference: [1] Journal of the Chemical Society, 1921, vol. 119, p. 1612[2] Journal of the Chemical Society, 1922, vol. 121, p. 1872
  • 13
  • [ 2042-14-0 ]
  • [ 16732-73-3 ]
Reference: [1] Journal of the Chemical Society, 1921, vol. 119, p. 1612[2] Journal of the Chemical Society, 1922, vol. 121, p. 1872
  • 14
  • [ 17484-36-5 ]
  • [ 16732-73-3 ]
Reference: [1] Journal of the Chemical Society, 1921, vol. 119, p. 1612[2] Journal of the Chemical Society, 1922, vol. 121, p. 1872
  • 15
  • [ 67-56-1 ]
  • [ 16732-73-3 ]
  • [ 98081-83-5 ]
YieldReaction ConditionsOperation in experiment
328 mg at 65℃; Inert atmosphere 6-Methoxy-lH-indole-2-carboxylic acid acid (1 g, 5.23 mmol, commercially available from, for example, Amfinecom Inc.) was dissolved in methanol (16 mL), to this solution HC1 (12.39 M, 1.689 mL, 20.92 mmol) was added. The reaction was stirred at 65 °C under nitrogen for 3 h. The reaction was left stirring at 65 °C under nitrogen overnight, LCMS showed 43percent) conversion to desired product. The reaction was left stirring at 65 °C under nitrogen for a further 4.5 h. The solution was then allowed to cool and taken to pH14 using NaOH (2 M). The desired product was filtered off to give the desired product (328 mg) a brown solid.LCMS (Method B): Rt = 0.92 min, MH+ = 442.1.
Reference: [1] Angewandte Chemie - International Edition, 2015, vol. 54, # 30, p. 8809 - 8813[2] Angew. Chem., 2015, vol. 127, # 30, p. 8933 - 8937,5
[3] Patent: WO2016/185279, 2016, A1, . Location in patent: Page/Page column 198
[4] Journal of Enzyme Inhibition and Medicinal Chemistry, 2018, vol. 33, # 1, p. 1225 - 1238
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 16732-73-3 ]

Ethers

Chemical Structure| 98081-83-5

[ 98081-83-5 ]

Methyl 6-methoxy-1H-indole-2-carboxylate

Similarity: 0.96

Chemical Structure| 111258-23-2

[ 111258-23-2 ]

Methyl 4-methoxy-1H-indole-2-carboxylate

Similarity: 0.93

Chemical Structure| 1542950-01-5

[ 1542950-01-5 ]

5-(4-Isobutoxyphenyl)-1H-pyrrole-2-carboxylic acid

Similarity: 0.89

Chemical Structure| 4382-54-1

[ 4382-54-1 ]

5-Methoxyindole-2-carboxylic acid

Similarity: 0.87

Chemical Structure| 1517011-20-9

[ 1517011-20-9 ]

5-(4-Isopropoxy-3-methylphenyl)-1H-pyrrole-2-carboxylic acid

Similarity: 0.86

Carboxylic Acids

Chemical Structure| 1542950-01-5

[ 1542950-01-5 ]

5-(4-Isobutoxyphenyl)-1H-pyrrole-2-carboxylic acid

Similarity: 0.89

Chemical Structure| 4382-54-1

[ 4382-54-1 ]

5-Methoxyindole-2-carboxylic acid

Similarity: 0.87

Chemical Structure| 1517011-20-9

[ 1517011-20-9 ]

5-(4-Isopropoxy-3-methylphenyl)-1H-pyrrole-2-carboxylic acid

Similarity: 0.86

Chemical Structure| 24610-33-1

[ 24610-33-1 ]

7-Methoxy-1H-indole-2-carboxylic acid

Similarity: 0.86

Chemical Structure| 1477-50-5

[ 1477-50-5 ]

1H-Indole-2-carboxylic acid

Similarity: 0.85

Related Parent Nucleus of
[ 16732-73-3 ]

Indoles

Chemical Structure| 98081-83-5

[ 98081-83-5 ]

Methyl 6-methoxy-1H-indole-2-carboxylate

Similarity: 0.96

Chemical Structure| 111258-23-2

[ 111258-23-2 ]

Methyl 4-methoxy-1H-indole-2-carboxylate

Similarity: 0.93

Chemical Structure| 4382-54-1

[ 4382-54-1 ]

5-Methoxyindole-2-carboxylic acid

Similarity: 0.87

Chemical Structure| 24610-33-1

[ 24610-33-1 ]

7-Methoxy-1H-indole-2-carboxylic acid

Similarity: 0.86

Chemical Structure| 1477-50-5

[ 1477-50-5 ]

1H-Indole-2-carboxylic acid

Similarity: 0.85